Results 241 to 250 of about 1,534,954 (286)
Some of the next articles are maybe not open access.

REGULATION OF PULMONARY RESISTANCE DURING CARDIOPULMONARY PRESERVATION

Transplantation, 1992
To characterize the neural and vasoactive mediators of pulmonary vasoconstriction and determine whether the beneficial effect of isoproterenol could be mimicked by other agents that increase cyclic adenosine monophosphate, heart and lung organ blocks were harvested from calves and studied in a normothermic autoperfusion circuit.
G J, Kontos   +3 more
openaire   +2 more sources

Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction

Cardiology Clinics, 2022
Heart failure with preserved ejection fraction (HFpEF) is a common medical condition associated with increased morbidity and mortality. Through different mechanisms, including passive left-sided congestion and/or vasculopathy, patients with HFpEF can develop pulmonary hypertension (PH).
Victor M, Moles, Gillian, Grafton
openaire   +2 more sources

Mainstream bronchial sleeve resection with pulmonary preservation

The Annals of Thoracic Surgery, 1996
Resection of a mainstem bronchus with pulmonary preservation is a therapeutic option when disease is limited to the mainstem bronchus. We reviewed our experience with this procedure to determine the operative morbidity, mortality, and long-term outcome.From January 1965 through January 1995, 22 patients (13 male, 9 female) underwent circumferential ...
R J, Cerfolio   +4 more
openaire   +2 more sources

Overview and Future Practice Patterns in Cardiac and Pulmonary Preservation

Journal of Cardiac Surgery, 2000
Heart and lung transplantation have become standard therapy for many patients with end-stage heart and lung disease. Successful transplantation requires preservation of allografts until they can be implanted and reperfused. In the decades since the transplantation of thoracic organs became a clinical reality, many advances have been made in ...
J V, Conte, W A, Baumgartner
openaire   +2 more sources

Pulmonary hypertension in heart failure with preserved ejection fraction

The Journal of Heart and Lung Transplantation, 2015
In heart failure with preserved ejection fraction (HFpEF), an entity that remains challenging and difficult to treat, the development of pulmonary hypertension (PH), via an increase in left atrial pressure, is the direct consequence of reduced relaxation and enhanced stiffness of the left ventricle and is now viewed as an important contributor to ...
Marco, Guazzi   +2 more
openaire   +2 more sources

Preserved muscle metaboreflex in chronic obstructive pulmonary disease

Applied Physiology, Nutrition, and Metabolism, 2011
The objective of this study was to measure the magnitude of the muscle metaboreflex in people with chronic obstructive pulmonary disease (COPD) compared with healthy controls and to assess the relationships between disease severity, exercise capacity, and the magnitude of the muscle metaboreflex.
Megan F B, Sherman   +3 more
openaire   +2 more sources

Bronchial Repair with Pulmonary Preservation for Severe Blunt Trauma

The Thoracic and Cardiovascular Surgeon, 2001
After a motorcycle accident, a 22-year-old male was diagnosed with multiple rib fractures, left-sided tension pneumothorax, hemothorax and left upper lobe bronchus rupture at its origin. An emergency left thoracotomy revealed an almost complete avulsion of the upper lobe bronchus from the main stem bronchus, a severely damaged pulmonary artery, and a ...
G, Rocco, M, Allen
openaire   +2 more sources

Preservation of a Regurgitant Quadricuspid Pulmonary Autograft by the David Procedure

The Annals of Thoracic Surgery, 2019
We report a case in which a quadricuspid pulmonary valve was used for the Ross operation in a young male patient. The patient demonstrated severe pulmonary autograft regurgitation due to a neosinus of Valsalva aneurysm 16 years after the primary operation.
Markus, Liebrich   +3 more
openaire   +2 more sources

Preserving Pulmonary Function: A Palliative Intervention

The Journal for Nurse Practitioners, 2019
Abstract Morbidity and mortality rates from advanced symptomatic pulmonary disease (APD) is a global concern. Of the 10 leading causes of death worldwide, 3 are pulmonary conditions. Ensuring accurate diagnosis and differentiating between obstructive and restrictive airways disease determines optimal patient outcomes.
openaire   +1 more source

Home - About - Disclaimer - Privacy